Pages

Saturday, December 5, 2015

Shkreli's KaloBios buys an old drug with eyes on a lucrative FDA ... FierceBiotech-21 hours ago KaloBios plans to file for the FDA's fast-track designation in hopes of scoring a quick approval for benznidazole without

Shkreli's KaloBios buys an old drug with eyes on a lucrative FDA...
FierceBiotech-21 hours ago
KaloBios plans to file for the FDA's fast-track designation in hopes of scoring a quick approval for benznidazole without

No comments:

Post a Comment